ImProDia For Profit
Improdia’s mission is to optimize personalized treatments for patients suffering from pathologies characterized by chronic inflammation. In the last half century the incidence and prevalence of these cases are steadily increasing, with further rises expected. Improdia is developing a kit, based on revolutionary biomarkers, that can evaluate the individuals’ immune status and inflammatory conditions by means of a simple, rapid, reliable and non-invasive blood test. This immune status detecting golden standard kit will enable Improdia to be a world leader in this widespread medical field.
Founded Date:
2012-01-01
Last Funding Type:
Seed
Headquarters:
Herzliya, Tel Aviv, Israel
Technology:
Biomarker panels
Employee Number:
Undisclosed
Industry:
Clinical Data Management
Number Of Exists:
Seed
Funding Status:
Seed
Investor Type:
Company
Investment Stage:
N/A
Total Funding:
âª3M